Human serum amyloid P component (SAP) is a glycoprotein structurally belong
ing to the pentraxin family of proteins, which has a characteristic pentame
ric organization. Mice with a targeted deletion of the SAP gene develop ant
inuclear Abs, which was interpreted as evidence for a role of SAP in contro
lling the degradation of chromatin. However, in vitro SAP also can bind to
phosphatidylethanolamine, a phospholipid which in normal cells is located m
ainly in the inner leaflet of the cell membrane, to be translocated to the
outer leaflet of the cell membrane during a membrane flip-Hop. We hypothesi
zed that SAP, because of its specificity for phosphatidylethanolamine, may
bind to apoptotic cells independent of its nuclear binding. Calcium-depende
nt binding of SAP to early, nonpermeable apoptotic Jurkat, SKW, and Raji ce
lls was indeed observed. Experiments with flip-flopped erythrocytes confirm
ed that SAP bound to early apoptotic cells via exposed phosphatidylethanola
mine. Binding of SAP was stronger to late, permeable apoptotic cells. Exper
iments with enucleated neutrophils, with DNase/RNase treatment of late apop
totic Jurkat cells, and competition experiments with histones suggested tha
t binding of SAP to late apoptotic cells was largely independent of chromat
in. Confocal laser microscopic studies indeed suggested that SAP bound to t
hese apoptotic cells mainly via the blebs. Thus, this study shows that SAP
binds to apoptotic cells already at an early stage, which raises the possib
ility that SAP is involved in dealing with apoptotic cells in vivo.